US drugmakers Moderna and Merck & Co last week released new data on the former’s intismeran autogene and Merck’s Keytruda in ...
US clinical-stage vaccines developer Vaxcyte on Friday provided updates on the continued advancement of VAX-31, the company’s ...
Last week, US pharma giant Pfizer chairman and chief executive Albert Bourla presented at the JP Morgan Healthcare Conference ...
Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and ...
US biopharma Corcept Therapeutics (Nasdaq: CORT) says its Phase III ROSELLA trial met its overall survival primary endpoint ...
In a new report, DelveInsight argues the gastroesophageal reflux disease market remains constrained by limited approved ...
Australian biotech Neurizon Therapeutics (ASX: NUZ) is setting out to redefine how neurodegenerative diseases are treated, ...
The Russian government has extended the permit for domestic pharmaceutical companies Promomed and PSK Pharma to produce ...
Belgian biopharma UCB has announced a capital boost from the UK government’s Life Sciences Innovative Manufacturing Fund ...
Japanese drugmaker Daiichi Sankyo has appointed Veronika Rozehnal to succeed Jürgen Müller as the Head of the Translational ...
Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today, the UK health technology assessor, National Institute ...
The USA has completed its withdrawal from the World Health Organization (WHO), according to a joint announcement by the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results